The Pharmaceutical Market: Serbia (pdf/xls)

The Pharmaceutical Market: Serbia (pdf/xls)


February 17, 2012
46 Pages - SKU: ESPI3790056
License type:
Online Download      US $1,085.00
Global Site License      US $7,095.00
Countries covered: Serbia and Montenegro

Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:
  • Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.
  • Specialised intelligence on OTCs, generics, biologics and biosimilars.
  • Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.
  • A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.
  • The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.


Additional Information

THE PHARMACEUTICAL MARKET: SERBIA - REVIEW

The economic situation is improving in Serbia; the economy is expected to grow by a moderate figure in 2011 and by an average 4.3% per annum between 2012 and 2016. Inflation has been fuelled by several administrative price increases, but is expected to fall by the end of 2011. Health expenditure growth will be slightly stronger than economic growth. In terms of the percentage of GDP spent on health, Serbia has the highest level of healthcare expenditure in the region. Most health spending is in the public sector, channelled through the obligatory health insurance system. Private sector expenditure is growing and accounts for an estimated 39.9% of the total in 2011, worth US$2.0 billion.

The Serbian pharmaceutical industry is well developed. The largest producers are Galenika, Hemofarm and Zdravlje, which together account for around 90% of domestic drug production. Most companies are privately-owned. In June 2010, Galenika opened a new solid pharmaceutical products factory, which will assist the company in becoming a regional leader in the sector. Foreign manufacturers are slowly increasing their presence in the country. At the end of 2010, the Serbian subsidiary of PharmaSwiss started the construction of a pharmaceutical manufacturing unit in Belgrade, which will allow it to extend its operations in Serbia from mainly repackaging and distribution, to end-to-end manufacturing.

The Serbian pharmaceutical market is one of the smallest in Central & Eastern Europe. Serbia has one of the lowest pharmaceutical per capita expenditures in the region, with spending similar to that found in Russia. However, the market is projected to increase by a moderate CAGR in the 2011-2016 period. This is one of the highest growth rates in the region, similar to Poland or Romania. The market is driven by strong import growth, although a decline was recorded in 2009 and 2010. Economic recovery will help to boost the expansion of the pharmaceutical market. In 2016, the Serbian pharmaceutical market will rank tenth in Central & Eastern Europe, similar to Bulgaria.

ENHANCED STRATEGIC INTELLIGENCE

Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:
  • Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.
  • Specialised intelligence on OTCs, generics, biologics and biosimilars.
  • Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.
  • A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.
  • The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.
HEALTHCARE STATISTICS

A comprehensive tabula review, comprising demographics, epidemiology, health expenditure, hospital and primary care infrastructure & services and healthcare personnel, is additionally included.

More Over-the-Counter Drugs reports by Espicom Healthcare Intelligence

The World OTC Medicine Market Report 2013 by Espicom Healthcare Intelligence
The World OTC Medicine Market Report 2013With the increasing availability of OTC medicines through non-pharmacist channels (supermarkets, petrol stations, kiosks etc) plus the global population’s ...
The World Pharmaceutical Markets Fact Book 2013 by Espicom Healthcare Intelligence
The indispensable source of thousands of facts, figures and statistics for 67 pharmaceutical markets worldwide! The World Pharmaceutical Market Fact Book 2013 is the ...
The Worldwide Pharmaceutical Market Forecast to 2018 by Espicom Healthcare Intelligence
The Worldwide Pharmaceutical Market Forecast to 2018 This analysis report is an essential resource for business forecasters, marketing planners, the investment community and anyone looking ...
The Pharmaceutical Market: Vietnam by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
See all reports like this >>

More Serbia and Montenegro Over-the-Counter Drugs reports

Dermatologicals in Serbia by Euromonitor International
Dermatologicals in SerbiaDermatologicals is relatively developed in Serbia as products have been available in most areas for decades. Distribution is also fine while consumer product ...
Consumer Health in Serbia by Euromonitor International
Consumer Health in SerbiaNot just over the review period, but also over the last 7-8 years, consumer health in Serbia has been flooded with good ...
Incontinence in Serbia by Euromonitor International
Incontinence in SerbiaAlthough the impact of stigma on sales performance slowly abates, the negative economic climate, which has particularly affected vulnerable older population, keeps incontinence ...
Herbal/Traditional Products in Serbia by Euromonitor International
Herbal/Traditional Products in SerbiaThe use of herbal/traditional products has been common in Serbia for decades. However, official figures do not support this fact. There are ...
See all reports like this >>

More Serbia and Montenegro reports

D&B Country RiskLine Report: Serbia by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
See all reports like this >>

 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!